Lloyd Jeffs | Strategic Customer Leader
Cytiva

Dr. Lloyd Jeffs joined Cytiva as part of the acquisition of Precision NanoSystems (PNI) in 2021. At PNI, Lloyd helped establish the Biopharma Services team that is responsible for developing and executing custom programs to meet the clinical manufacturing needs of Cytiva’s Nanomedicine clients. Lloyd is an expert in developing lipid-based nanotherapeutics and has over 25 years of experience in this field, including formulation and process development, scale-up and technology transfer. Dr. Jeffs received his PhD. in Applied Microbiology from the University of Saskatchewan and has B.Sc. and M.Sc. degrees from the University of British Columbia. He is a co-author of numerous peer reviewed publications dealing with the development of lipid nanoparticle therapeutics and is a co-inventor for key RNA-LNP patents in this field.